SCHEMBL6745197

SCHEMBL6745197

O=Cc1cc(CO)cs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12914552 0.83 DAO (0.33)
Ethylene SCHEMBL9454407 0.80 LMNA (0.33)
SCHEMBL5999186 0.79 ERN1 (0.44)
SCHEMBL3252591 0.78
SCHEMBL5803353 0.75 MGLL (0.32)
SCHEMBL4326061 0.75 EGFR (0.46)
SCHEMBL4326058 0.75 EGFR (0.46)
SCHEMBL8586379 0.74 DPP4 (0.49)
SCHEMBL3904764 0.74 ALDH1A1 (0.32)
SCHEMBL30579025 0.74 ERN1 (0.35)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3071578-B1 TRICYCLIC PIPERIDINE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2018-01-10 EP disclosed
US-9765092-B2 Tricyclic piperidine compounds ACTELION PHARMACEUTICALS LTD (CH) 2017-09-19 US disclosed
CN-106999479-A It can be used as the heteroaryl compound of SUMO activating enzyme inhibitors 米伦纽姆医药公司 2017-08-01 CN disclosed
EP-3071578-A1 TRICYCLIC PIPERIDINE COMPOUNDS Actelion Pharmaceuticals Ltd (CH) 2016-09-28 EP disclosed
US-20160272655-A1 TRICYCLIC PIPERIDINE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2016-09-22 US disclosed
CN-105745214-A Tricyclic piperidine compounds 埃科特莱茵药品有限公司 2016-07-06 CN disclosed
WO-2015075023-A1 TRICYCLIC PIPERIDINE COMPOUNDS ACTELION PHARMACEUTICALS LTD (CH) 2015-05-28 WO disclosed
US-6703373-B1 ANTICARCINOGENIC AGENTS BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-03-09 US disclosed